The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine
Hayley C. Whitaker(University of Cambridge), David E. Neal(University of Cambridge), Daniel Leongamornlert(University of Southern California), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Helen Ross‐Adams(Jagiellonian University), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Sameer Jhavar(National Cancer Institute), Anne Y. Warren(Cambridge University Hospitals NHS Foundation Trust), Jimmy Lam(Flinders Medical Centre), Douglas F. Easton(University of Cambridge), Zsofia Kote‐Jarai(Institute of Cancer Research), Johanna Burge(Cancer Research UK), Kathy Tucker(UNSW Sydney), Hans Lilja(Memorial Sloan Kettering Cancer Center), Wendy S. Rubinstein(National Cancer Institute), Anne George(University of Illinois Chicago), Edward J. Saunders(Institute of Cancer Research), Ignacio Blanco(Hospital Universitari Germans Trias i Pujol), Geoffrey J. Lindeman(The University of Melbourne), Huw Dorkins(London North West Healthcare NHS Trust), Alison Male(Great Ormond Street Hospital), D. Gareth Evans(Manchester Academic Health Science Centre), Judy Kirk(The University of Sydney), Malgorzata Tymrakiewicz(Institute of Cancer Research), Alan M. F. Stapleton(Repatriation General Hospital), Virginia Clowes(London North West Healthcare NHS Trust), Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), Lisa Walker(Oxford University Hospitals NHS Trust), Fiona Douglas(University of Southern California), Catherine Mercer, Gillian Mitchell(Peter MacCallum Cancer Centre), Elizabeth Page(Institute of Cancer Research), Colin Cooper(Institute of Cancer Research), Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Shirley Hodgson(St Thomas' Hospital), Anita Mitra(University College Hospital)
Cited by 81
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k